Abstract

The present invention relates, generally, to beta-lactones comprising a spiro-fused ring and one beta-lactone ring and derivatives thereof, in particular an unprecedented macrolide named spirolactone, and their use as antimicrobial agents.

Original languageEnglish
IPCC12N 1/ 00 A I
Patent numberWO2024003331
Filing date30/06/2022
Country/TerritoryInternational Bureau of the World Intellectual Property Organization (WIPO)
Priority date30/06/2022
Priority numberEP20220182256
Publication statusPublished - 4 Jan 2024

Fingerprint

Dive into the research topics of 'Spirolactone as a novel antimicrobial lead'. Together they form a unique fingerprint.

Cite this